Establishment Labs Holdings Inc. (ESTA)

Market Cap	2.00B +14.0%
Revenue (ttm)	264.03M +38.3%
Net Income	-38.45M
EPS	-1.28
Shares Out	29.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	321,680
Open	63.91
Previous Close	64.42
Day's Range	63.08 - 67.98
52-Week Range	53.16 - 97.59
Beta	1.00
Analysts	Strong Buy
Price Target	98.00 (+46.23%)
Earnings Date	Oct 29, 2026

About ESTA

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and i...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 19, 2018
• Employees: 1,004
• Stock Exchange: Nasdaq
• Ticker Symbol: ESTA
• Website: https://www.establishmentlabs.com

Financial Performance

In 2025, ESTA's revenue was $211.08 million, an increase of 27.14% compared to the previous year's $166.03 million. Losses were -$51.06 million, -39.64% less than in 2024.

Analyst Summary

According to 10 analysts, the average rating for ESTA stock is "Strong Buy." The 12-month stock price target is $98.0, which is an increase of 46.23% from the latest price.

Price Target

$98.0

(46.23% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 9, 2026

Data Sources Report a data error